Clinical Trial Update: Effect of Evolocumab on Carotid Plaque Composition in Asymptomatic Carotid Artery Stenosis (EVOCAR-1) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of evolocumab on carotid plaque composition in asymptomatic carotid artery stenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Artery Stenosis

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Imperial College Healthcare NHS Trust | Conditions: Carotid Artery Stenosis | Phase 4 | Status: UNKNOWN